Sol-Gel Technologies (NASDAQ:SLGL) Trading 5.2% Higher – What’s Next?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL)’s stock price traded up 5.2% on Wednesday . The company traded as high as $0.60 and last traded at $0.59. 11,111 shares were traded during mid-day trading, a decline of 96% from the average session volume of 252,685 shares. The stock had previously closed at $0.56.

Sol-Gel Technologies Stock Up 5.2 %

The stock has a market cap of $16.38 million, a price-to-earnings ratio of -1.73 and a beta of 1.29. The stock’s 50 day moving average price is $0.68 and its two-hundred day moving average price is $0.69.

Hedge Funds Weigh In On Sol-Gel Technologies

A hedge fund recently bought a new stake in Sol-Gel Technologies stock. Raymond James Financial Inc. bought a new position in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 108,990 shares of the company’s stock, valued at approximately $101,000. Raymond James Financial Inc. owned 0.39% of Sol-Gel Technologies as of its most recent SEC filing. 26.18% of the stock is currently owned by institutional investors.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.